Regeneron Pharmaceuticals (REGN) YTD return
Updated November 02, 2026 · Data: Yahoo Finance
Price chart
REGN vs its sector
Underperforming its sector. REGN is 4.71 points behind the Health Care sector average, which covers 60 ranked S&P 500 stocks.
Regeneron Pharmaceuticals (REGN) is up +25.02% year-to-date in 2026, ranking #147 of 500 ranked S&P 500 stocks. It closed 2025 at $768.89 and trades at $961.26 as of November 02, 2026. $1,000 invested on December 31, 2025 would be worth $1,250.20 today. That puts it 4.71 points behind the Health Care sector average of +29.73%.
Recent performance
Regeneron Pharmaceuticals (REGN) has gained 30.75% over the past month, outpacing the S&P 500 by 33.10%, and gained 26.52% over the past three months (ahead of the index by 29.04%). It is trading at its 52-week high. Momentum is positive: the stock rose in at least 4 of the last 5 sessions.
Latest REGN news
- The top 5 analyst questions from Regeneron’s Q3 earnings callStockStory · 2026-11-02
- BMO Raises Price Target on Regeneron Pharmaceuticals to $1,050 From $920, Keeps Outperform RatingMT Newswires · 2026-11-02
- US Stock Market Today: S&P 500 Futures Edge Higher On ISM Manufacturing TestSimply Wall St. · 2026-11-02
- RBC Raises Price Target on Regeneron Pharmaceuticals to $913 From $810, Keeps Sector Perform RatingMT Newswires · 2026-11-02
- Cantor Fitzgerald Adjusts Price Target on Regeneron Pharmaceuticals to $980 From $795MT Newswires · 2026-11-02
Headlines via Yahoo Finance, updated daily.
Where to invest in REGN
Popular stock brokerages:
We may earn a commission if you sign up through these links, at no extra cost to you.
REGN YTD return FAQ
What is Regeneron Pharmaceuticals (REGN)'s YTD return in 2026?
Regeneron Pharmaceuticals (REGN) is up +25.02% year-to-date in 2026, as of November 02, 2026.
What was Regeneron Pharmaceuticals (REGN)'s price at the start of 2026?
Regeneron Pharmaceuticals (REGN) closed at $768.89 on December 31, 2025 and trades at $961.26 as of November 02, 2026.
Where does Regeneron Pharmaceuticals (REGN) rank by YTD return in 2026?
Regeneron Pharmaceuticals (REGN) ranks #147 of 500 S&P 500 stocks by YTD return in 2026, as of November 02, 2026.
For informational purposes only, not financial advice.
About · Contact · Privacy Policy · Affiliate Disclosure · Methodology
© 2026 MZX MEDIA LLC. All rights reserved.